Xanadu Bio

$23Mtotal raised · 2 rounds on record
$11Mlatest round · Venture round · Aug 2025 · 14 mo ago
50+team · employees, estimated range
2021founded

Funding and backers

Total raised
$23M
2 rounds on record
Latest round
$11M
Venture round · Aug 2025 · 14 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 13, 2025 Raised a round Venture round $11M · SEC Form D Aug 16, 2022 Raised a round Venture round $12M · SEC Form D 2021 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Aug 2025 $11M — SEC Form D
Venture round Aug 2022 $12M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Xanadu Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Bruce TurnerDirector, Executive OfficerSEC Form D
Todd WiderDirector, Executive OfficerSEC Form D
Taylor FeehleyExecutive OfficerSEC Form D

Financials

Total raised
$23M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $11M Details
Venture - Series Unknown 2022 $12M Details

People

Bruce Turner
Director, Executive Officer
SEC Form D
Todd Wider
Director, Executive Officer
SEC Form D
Taylor Feehley
Executive Officer
SEC Form D
Mark Saltzman
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Gladwyne United States
HQ
50-200 est. staff